secwatch.observer — SEC 8-K summary
======================================

Issuer:     PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
CIK:        0001299130
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001299130-24-000189
Event type: debt
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacific Biosciences exchanges $459M 2028 notes for $200M new notes, shares, and $50M cash
--------------------------------------------------------------------------------

- Exchanged $459M of 1.50% 2028 notes for $200M new 1.50% notes due 2029, 20,451,570 shares, and $50M cash.
- All $459M of the 2028 notes have been cancelled; no cash proceeds received by the company.
- New notes mature August 15, 2029, convertible at ~$4.89/share, callable after Aug 2027 if stock >150% of conversion.
- Side letter with SBN restricts new debt and liens; right of first refusal if going-concern doubt triggers up to $200M.
- Covenants include no indebtedness maturing before 2029 (except permitted) and no guarantees without equal treatment of notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000189/0001299130-24-000189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1299130/000129913024000189/pacb-20241121.htm
  HTML page:      https://secwatch.observer/filing/0001299130-24-000189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer